We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

IOM Urges Vigorous, Consistent Process For Evaluating Food, Supplement Health Claims

May 12, 2010: 08:36 AM EST
In a report sponsored by the FDA, the U.S. Institute of Medicine urged the agency to take as vigorous a regulatory approach toward food and nutritional supplement health claims as it does toward medication and medical technology approvals. The IOM said there is no scientific reason to use different standards when assessing the health benefit claims of food ingredients and drugs. They both can significantly affect people's well-being. According to the IOM, the FDA has been hampered in evaluating food supplement health claims because it does not have a broadly accepted assessment process. The IOM suggested a consistent framework the FDA could use to judge the validity of biomarkers used in studies provided as evidence to support product health and safety claims.
"IOM Report Recommends Framework to Evaluate Science Behind Health Claims for Foods and Drugs; Calls for Equal Rigor in Assessing Food Claims and Drug Approvals", The National Academies, May 12, 2010
Food Safety
External Guidance & Action
Policy & Regulation
Quality & Internal Procedures
North America
United States of America
Companies, Organizations
Legal, Legislation, Regulation, Policy
Developed by Yuri Ingultsov Software Lab.